Citatuzumab (Anti-EpCAM / TROP1 / CD326)
Citatuzumab (Anti-EpCAM / TROP1 / CD326) is a recombinant immunotoxin that composed of humanized monoclonal antibody targeting EpCAM. It has antitumor activity and can be used in treatment of cancer. MW :145.4 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2651 |
| Sku # | A2651-1mg*5 |
| Pricing | 1mg*5, $1690.00 |